Phase 1
๐ Investigational Drug / Biologic
NCT06385080
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
๐ University of California at San Diego Moores Cancer Center โ La Jolla, California
View Study & Screener โ